Navigation Links
The Shapes Of Life: NIGMS Project Yields More Than 1,000 Protein Structures

The Protein Structure Initiative (PSI), a national program aimed at determining the three-dimensional shapes of a wide range of proteins, has now determined more than 1,000 different structures. These structures will shed light on how proteins function in many life processes and could lead to targets for the development of new medicines.

The PSI is a 10-year, approximately $600 million project funded largely by the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health. The first half of this project ?a pilot phase that started in 2000 ?has centered on developing new tools and processes that enable researchers to quickly, cheaply, and reliably determine the shapes of many proteins found in nature.

“One thousand protein structures is a significant milestone for the PSI, and it shows an impressive return on the investment in the technology and methods for rapid structure determination,?said Jeremy M. Berg, Ph.D., director of NIGMS. “These structures are interesting in their own right and provide the basis for modeling many important proteins.?/p>

Some of the newly determined structures are of proteins found in plants, mice, yeast, and bacteria, including the pathogenic types that cause pneumonia, anthrax, and tuberculosis.

The nine PSI pilot centers have transformed protein structure determination from a mostly manual process to a highly automated one. Robotic instruments rapidly clone, express, purify, crystallize, and analyze many proteins simultaneously, cutting the time it takes to determine a single protein structure from months to days. For example, a robotic arm drops protein solution into thousands of tiny wells for crystallization trials, and an imaging system quickly scans the wells looking for signs of crystal formation ?key to capturing protein structures.

“At this large scale, it would be unthinkable to do all these steps by hand,?said John Norvell, Ph.D., director of the PSI at
'"/>

Source:NIH/National Institute Of General Medical Sciences


Page: 1 2 3

Related biology news :

1. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
2. Whole genome promoter mapping - Human Genome Project v2.0?
3. Knockout Mouse Project
4. Research on Worms Yields Clues on Aging
5. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
6. A step toward the $1,000 personal genome using readily available lab equipment
7. Students discover 11,000 year old remains of Irish Elk
8. Boston University biomedical engineers win major grant for pursuit of the $1,000 Genome
9. Scientists win grants to develop $1,000 genome sequencing technology
10. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
11. Protein discovery could unlock the secret to better TB treatment

Post Your Comments:
(Date:11/20/2009)...9 - Bacteria possess an ingenious mechanism for pr...f the cell. This is the new finding of a team of b...fe sciences research institute in Flanders, Belgiu...e scientists made this discovery by modifying the .... By means of this model organism, they have uncov...
(Date:11/20/2009)...ary disease (COPD), a respiratory disease commonly...fourth leading cause of death worldwide. 600 mill...ve yet to find any real treatment or cure, Grace P...sity of Western Ontario in London, Canada, is usin...nto the disease. , Parraga is a scientist in...
(Date:11/19/2009)... brain chemical with an unwieldy name: 4-hydroxybu... used as a date-rape drug. , Now, a team of Ohi...es by which 4-HB is metabolized by the body. "This...l Gibson, professor and chair of biological scienc...er of the research team. "It may provide new clue...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2Florida State Tobacco Tax Increase May Prompt Smokers to Quit Spontaneously 50601 1Florida State Tobacco Tax Increase May Prompt Smokers to Quit Spontaneously 50601 2Florida State Tobacco Tax Increase May Prompt Smokers to Quit Spontaneously 50601 3ISPA Releases 2009 U S Spa Industry Statistics 50596 1ISPA Releases 2009 U S Spa Industry Statistics 50596 2Growth Hormone May Build Muscle in Older Men 50591 1Growth Hormone May Build Muscle in Older Men 50591 2
...s announces the latest addition to its Cumulative ... (Cumitechs) publication series: Cumitech 46 -- L... Parasitic Diseases. , This Cumitech is intended ...d other members of the patient care team in the ap...ests for the diagnosis and management of blood-bor...
...ch team has developed the first small molecule tha...n balancing sodium levels, paving the way for drug...nditions. , The human epithelial sodium channel ...ch as the lungs, kidneys, and colon, and it is vit...essure. Interestingly, while there are available d...
...born in India and Sri Lanka are three times more l...n pregnancy (hyperemesis gravidarum) than ethnic N...nstitute of Public Healths study of 900, 000 first...Registry of Norway over a forty year period. , E...t women experience some degree of nausea and vomit...
Other Biology News:Extreme nausea and vomiting varies among pregnant women from different countries 2
(Date:11/19/2009)... like to be able to charge their cell phones and o...n. A recent discovery made by UC San Diego enginee...tors that could do just this. , In recent resea...akar Bandaru, a professor in the UCSD Department o... graduate student Mark Hoefer, have found that art...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 ...or in biotechnology for diabetes therapy, and a pr...ices to food, supplement, biotechnology and pharma...previously reported $6.3 million registered direct... shares of its common stock and warrants to purcha...
(Date:11/19/2009)...STER, Germany, November 19 MONITOR...ovember 16th, 2009 Flibanserin in the,indication t...arkinson,s,disease for orphan drug status designat...odopa-induced dyskinesia is a complication of the ...erious burden to some of those,affected, since it ...
(Date:11/19/2009)... InSound is honored by latest award for revolu...wark, CA (PRWEB) November 16, 2009 -- Popular Scie...rdquo; hearing aid from InSound Medical a winner o...e Health category.    Chosen f...side deep in the hearing canal for up to four mont...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...ate Conference Call and Webcast on March 14 at 8:0...AN DIEGO, March 13 Halozyme Therapeutics,Inc. (Na...ing and,commercializing products targeting the ext...s for the three months and year ended December 31,...ur partnered programs, while,building a strong fou...
...ch 13 /PRNewswire-FirstCall/ - Angiotech Pharmaceu...pecialty pharmaceutical and,medical device company...idated financial statements and Management,s Discu... 2007 and the restatement of its audited,consolida...er 31, 2006., For the year ended December 31, 200...
... Patent Challenge Underway -, CORONA, Calif., Mar... a leading specialty pharmaceutical,company, today...ug,Application (ANDA) with the U.S. Food and Drug ...s Levonorgestrel and Ethinyl Estradiol tablets, US...ive product prior to the,expiration of patents own...
Other Biology Technology:Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 2Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 3Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 4Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 5Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 6Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 7Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 8Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 2Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 3Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 4Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 5Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 6Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 7Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 8Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 9Watson Files FDA Application for Generic LYBREL(R) 2
Mouse Anti-Human KRT4 Monoclonal Antibody, Unconjugated, Clone 5H5 from Abnova Corporation
Mouse Anti-Human ARHGEF11 Monoclonal Antibody, Unconjugated, Clone 2F4 from Abnova Corporation
...es ,High Quality, Functionally-Validated, Ion Chan...having a critical role in nerve and muscle functio...S and the heart. Drugs that modulate ion channels ...as neuropathic pain, cardiac arrhythmia, hypertens...
...es ,High Quality, Functionally-Validated, Ion Chan...having a critical role in nerve and muscle functio...S and the heart. Drugs that modulate ion channels ...as neuropathic pain, cardiac arrhythmia, hypertens...
Biology Products: